• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓形成可能是先天性肢体缺失的一个原因吗?

May thrombosis be a cause of congenital extremity absence?

作者信息

Genc Gurkan, Atay Nilgun Erkek, Kepenekli Eda, Yarali Nese

机构信息

Department of Pediatrics, Dr. Sami Ulus Children's Hospital, Ankara, Turkey.

出版信息

Indian J Pediatr. 2007 May;74(5):497-9. doi: 10.1007/s12098-007-0086-y.

DOI:10.1007/s12098-007-0086-y
PMID:17526965
Abstract

Congenital extremity anomalies have many modes of presentation. Interruption of vascular supply with thrombophily is a rare cause of congenital extremity absence. Here it is presented a 7 mth old male with absence of the left lower extremity. Laboratory tests revealed Factor V Leiden and Prothrombin G20210A heterozygote mutation and that was as the cause of extremity absence. At the patients with congenital extremity absences, it is not imprudent to explore a possible thrombophilic mutation along with other known etiologic factors.

摘要

先天性肢体异常有多种表现形式。伴有血栓形成倾向的血管供应中断是先天性肢体缺失的罕见原因。本文介绍了一名7个月大的男性,其左下肢缺失。实验室检查发现存在因子V莱顿突变和凝血酶原G20210A杂合子突变,这就是肢体缺失的原因。对于先天性肢体缺失的患者,探究可能存在的血栓形成倾向突变以及其他已知病因并不轻率。

相似文献

1
May thrombosis be a cause of congenital extremity absence?血栓形成可能是先天性肢体缺失的一个原因吗?
Indian J Pediatr. 2007 May;74(5):497-9. doi: 10.1007/s12098-007-0086-y.
2
Upper extremity deep vein thrombosis in a young patient double heterozygous for factor V Leiden and prothrombin G20210A mutation.
Clin Appl Thromb Hemost. 2001 Jan;7(1):72-4. doi: 10.1177/107602960100700114.
3
Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.印度中部镰状细胞病患者中因子 V 莱顿、凝血酶原 G20210A 和 MTHFR C677T 突变的临床影响。
Eur J Haematol. 2013 Nov;91(5):462-6. doi: 10.1111/ejh.12190. Epub 2013 Sep 16.
4
Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American population.美国中西部人群中凝血酶原G20210A突变与因子V莱顿突变的关联。
Am J Clin Pathol. 2000 Aug;114(2):272-5. doi: 10.1309/LQKG-F0D4-C6FF-FNEH.
5
Thrombosis in children with cardiac pathology: frequency of factor V Leiden and prothrombin G20210A mutations.患有心脏疾病儿童的血栓形成:凝血因子V Leiden和凝血酶原G20210A突变的发生率
Pediatr Cardiol. 2003 May-Jun;24(3):244-8. doi: 10.1007/s00246-002-0170-z. Epub 2003 Jan 15.
6
Factor V Leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behcet's disease.白塞病血栓形成患者的凝血因子V莱顿突变和PAI-1基因4G/5G基因型
Blood Coagul Fibrinolysis. 2003 Feb;14(2):121-4. doi: 10.1097/00001721-200302000-00001.
7
Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.凝血酶原G20210A变异体和因子V莱顿突变携带者发生静脉血栓形成的风险及其与口服避孕药的相互作用。
Haematologica. 2000 Dec;85(12):1271-6.
8
The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.凝血因子V Leiden和凝血酶原G20210A突变的杂合携带者发生复发性深静脉血栓形成的风险。
N Engl J Med. 1999 Sep 9;341(11):801-6. doi: 10.1056/NEJM199909093411104.
9
Livedoid vasculiltis associated with a double heterozygous Factor V Leiden and prothrombin G20210A gene mutations.与双重杂合子因子 V 莱顿和凝血酶原 G20210A 基因突变相关的 livedoid 血管炎。
Clin Exp Dermatol. 2009 Dec;34(8):e811-3. doi: 10.1111/j.1365-2230.2009.03541.x. Epub 2009 Sep 28.
10
Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.因子 V 莱顿和凝血酶原 G20210A 纯合子携带者和双重杂合子携带者复发性静脉血栓形成的风险。
Circulation. 2010 Apr 20;121(15):1706-12. doi: 10.1161/CIRCULATIONAHA.109.906347. Epub 2010 Apr 5.

本文引用的文献

1
Prevalence of factor V Leiden and prothrombin G20210A gene mutation.凝血因子V莱顿突变和凝血酶原G20210A基因突变的患病率。
Saudi Med J. 2005 Apr;26(4):580-3.
2
[Amniotic band syndrome: pathogenesis, prenatal diagnosis and neonatal management].[羊膜带综合征:发病机制、产前诊断及新生儿处理]
J Gynecol Obstet Biol Reprod (Paris). 2003 Dec;32(8 Pt 1):693-704.
3
Factor V Leiden and prothrombin gene 20210A variant in neonatal thromboembolism and in healthy neonates and adults: a study in a single center.新生儿血栓栓塞以及健康新生儿和成人中的凝血因子V莱顿突变和凝血酶原基因20210A变异:单中心研究
Pediatr Hematol Oncol. 2003 Dec;20(8):627-34.
4
Haemostatic gene polymorphisms in venous and arterial thrombosis.静脉和动脉血栓形成中的止血基因多态性。
Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):213-5. doi: 10.1159/000073568.
5
Multiple arterial thrombi and in utero leg gangrene in an infant of a diabetic mother.一位糖尿病母亲的婴儿出现多发性动脉血栓及宫内腿部坏疽。
J Perinatol. 2002 Jul-Aug;22(5):424-7. doi: 10.1038/sj.jp.7210741.
6
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.凝血因子V莱顿突变与凝血酶原20210A联合作用对静脉血栓栓塞风险的影响——对8项病例对照研究的汇总分析,包括2310例病例和3204例对照。静脉血栓栓塞汇总分析研究组
Thromb Haemost. 2001 Sep;86(3):809-16.
7
Limb deficiencies in newborn infants.新生儿肢体缺损
Pediatrics. 2001 Oct;108(4):E64. doi: 10.1542/peds.108.4.e64.
8
Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis.成人土耳其血栓患者的两种常见遗传性血栓形成危险因素:凝血因子V莱顿突变和凝血酶原G20210A突变
Am J Hematol. 2001 Jun;67(2):107-11. doi: 10.1002/ajh.1087.
9
Early occlusion of coronary by-pass associated with the presence of factor V Leiden and the prothrombin 20210A allele: case report.
Blood Coagul Fibrinolysis. 1999 Oct;10(7):443-6. doi: 10.1097/00001721-199910000-00008.
10
Small for gestational age infant in association with maternal prothrombin gene variant (nt 20210A).
Eur J Obstet Gynecol Reprod Biol. 1999 Apr;83(2):143-4. doi: 10.1016/s0301-2115(98)00330-3.